B4GALT1 and hematopoietic and lymphoid cell neoplasm: The wide variety of TFBS suggests that B4GALT1 contains a super-enhancer region and thus emerges as a previously unrecognized gene that regulates cell identity, disease, and promotes multidrug resistance in hematologic cancers resistance27,28.